(Q114686061)

English

Contract Drug Manufacturer Catalent to Buy Paragon Bioservices in $1.2 Billion Deal

Wall Street Journal article (April 14, 2019)

In more languages
default values for all languages
No label defined

No description defined

Statements

0 references
Contract Drug Manufacturer Catalent to Buy Paragon Bioservices in $1.2 Billion Deal (English)
0 references
0 references
0 references
14 April 2019
0 references
SB11758512012290754179704585243142420534732
0 references
464
0 references
SB11758512012290754179704585243142420534732
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit